Description: Gufic Biosciences Limited engages in the manufacture and marketing of active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India. It manufactures APIs and bulk drugs, such as antifungals, anaesthetics, and immuno suppressants, as well as intermediates for antifungals. The company also manufactures lyophilized injections, which include antibiotic, antifungal, cardiac, infertility, antiviral, and proton-pump inhibitor segments. In addition, it offers spark, criti care, and ferticare pharmaceutical products; and herbal and personal care products. The company supplies its products to hospital chains and medical facilities. It also exports its products. The company was founded in 1970 and is based in Mumbai, India.
Home Page: gufic.com
SM House
Mumbai,
400057
India
Phone:
91 22 6726 1000
Officers
| Name | Title |
|---|---|
| Mr. Jayesh Pannalal Choksi | Chairman & MD |
| Mr. Pranav Jayesh Choksi | CEO & Whole Time Director |
| Mr. Devkinandan B. Roonghta | Chief Financial Officer |
| Ms. Ami Naresh Shah | Company Sec., Compliance Officer & Exec. of Legal |
| Mr. Pankaj Jayakumar Gandhi | Whole-Time Director |
| Mr. Y. Nagesh | Chief Operating Officer |
| Dr. Debesh Das | Vice-Pres of Ethical Sales & Marketing |
Exchange: BSE
Country: IN
Currency: Indian Rupee (INR)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 77.0886 |
| Price-to-Book MRQ: | 9.8897 |
| Price-to-Sales TTM: | 2.9733 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 1044 |